Apop Biosciences is at the forefront of developing and bringing to market a range of innovative imaging, therapeutic, and diagnostic products for apoptosis and autophagy, based on our proprietary calcitonin receptor antibody technology CalRexin™.

Non-Executive Director, Apop Biosciences is at the forefront of developing and bringing to market a range of innovative imaging, therapeutic, and diagnostic products based on our proprietary calcitonin receptor antibody technology CalRexin™.

BMC is an Australian owned Clinical Research Organisation (CRO) and business advisory service with a focus and passion for early stage enterprises. Clinical research is critical in achieving risk mitigating milestones by demonstrating safety and/or efficacy parameters for medical products. At BMC, we leverage our international experience and networks in the commercialization of medical technologies to provide strategic advice to medical technology organisations. Our goal is to ensure our clients achieve important milestones and maximise limited resources. Our two core activities are:1. CRO/ Clinical Trial Support: We work with clients to develop clinical investigational plans and act as a local CRO for human studies by executing the clinical trial. 2. BMC business advisory service: We work with a variety of clients to develop global commercialisation plans. http://www.baronsmed.com/

At NAVi, we are on a mission to transform how Umbilical Venous Catheterisation procedures are being performed, and to ultimately enable better care for patients. I am working with the team assisting with commercialization activities. https://www.navitechnologies.com/

Health Delivered offers a cloud based platform that integrates complex scientific information, lifestyle and food preferences and a range of medical conditions to create personalised meal plans in minutes.https://www.healthdelivered.com.au/

As CEO of our Accelerator Group, I identified how Trajan can facilitate the growth of our Accelerator Companies and whole business support through marketing, compliance, HR and global supply chain expertise etc. The role included due diligence in multiple early stage companies and I lead the investment into Health Delivered. Trajan’s active investment in the Accelerator program aims to help start-ups cross the “Valley of Death” and build long term sustainable businesses.

Medical Device start-up company in the cardiovascular intervention sector acquired by Abbott Laboratories in 2001. Responsibilities included development of product applications from concept to market. Support of human clinical trials, development and execution of sales distribution and marketing for medical devices.